Gregory Y.H. Lip

Gregory Y.H. Lip publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gregory Y.H. Lip sits on this spectrum.

Gregory Y.H. Lip D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gregory Y.H. Lip sits on this spectrum.

Research.com Recognitions

• 2026 - Research.com Medicine in United Kingdom Leader Award
• 2025 - Research.com Best Scientists Award
• 2025 - Research.com Medicine in United Kingdom Leader Award
• 2023 - Research.com Medicine in United Kingdom Leader Award
• 2022 - Research.com Medicine in United Kingdom Leader Award
• Fellow of the American College of Cardiology (ACC)
• Fellow of the American College of Cardiology (ACC)
• Fellow of the American College of Cardiology (ACC)

Overview

Best Publications

• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

  Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  20522
  Citations

• 2007 Guidelines for the management of arterial hypertension

  Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova

  15293
  Citations

• Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

  Gregory Y. H. Lip;Robby Nieuwlaat;Ron Pisters;Deirdre A. Lane

  9240
  Citations

• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

  Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson

  9080
  Citations

• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  7360
  Citations

• A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

  Ron Pisters;Deirdre A. Lane;Robby Nieuwlaat;Cees B. de Vos

  5156
  Citations

• 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

  Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada

  4575
  Citations

• Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

  Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist

  3539
  Citations

• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

  Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich

  3264
  Citations

• 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

  Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  3116
  Citations

• 2018 ESC/ESH Guidelines for the management of arterial hypertension : The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

  Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei

  2896
  Citations

• Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

  Jan Heeringa;Deirdre A.M. van der Kuip;Albert Hofman;Jan A. Kors

  2613
  Citations

• 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

  Jose Luis Zamorano;Patrizio Lancellotti;Daniel Rodriguez Muñoz;Victor Aboyans

  2408
  Citations

• 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

  Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  2189
  Citations

• Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

  Jonathan Mant;FD Richard Hobbs;Kate Fletcher;Andrea Roalfe

  2179
  Citations

• 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

  Jose Luis Zamorano;Patrizio Lancellotti;Daniel Rodriguez Munoz;Victor Aboyans

  2089
  Citations

• Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

  Jonas Bjerring Olesen;Gregory Y H Lip;Morten Lock Hansen;Peter Riis Hansen

  1632
  Citations

• Guidelines on the Management of Valvular Heart disease (Version 2012)

  Alec Vahanian;Ottavio Alfieri;Felicita Andreotti;Manuel J. Antunes

  158
  Citations

• The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

  A. John Camm;Paulus Kirchhof;Gregory Y. H. Lip

  137
  Citations

• 2018 ESC/ESH guidelines for the management of atrial hypertension

  Bryan William;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti-Rosei

  0
  Citations